4.5 Review

Clinical interventions to break the obesity and cancer link: a narrative review

期刊

CANCER AND METASTASIS REVIEWS
卷 41, 期 3, 页码 719-735

出版社

SPRINGER
DOI: 10.1007/s10555-022-10055-1

关键词

Cancer; Obesity; Anti-obesity medication; Bariatric surgery; Weight loss

类别

资金

  1. Obesity Medicine Fellowship Council
  2. National Cancer Institute/National Institutes of Health [P30 CA006973]

向作者/读者索取更多资源

Excess body weight is a significant risk factor for the development and recurrence of many types of cancer. Weight loss and maintaining a healthy body weight can reduce complications and recurrence for cancer patients.
Excess body weight is a significant risk factor for the development and recurrence of many types of cancer. Patients with a history or current diagnosis of cancer who are overweight or have obesity have an increased risk of cancer treatment-related morbidity, recurrence, and decreased quality of life. Weight loss and maintenance of a healthy body weight may reduce cancer morbidity and recurrence in cancer survivors. While guidelines for cancer survivorship elaborate sufficiently on lifestyle interventions, little guidance is provided when considering additional therapies like anti-obesity pharmacotherapy or bariatric surgery for weight loss. This review will highlight and address current recommendations and feasible interventions that clinicians may consider to further reduce the incidence and recurrence of cancer in patients with obesity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据